Check4Cancer wins ‘Innovation in Health Tech’ award at the 2021 Laing Buisson Awards

Check4Cancer is delighted to announce that ‘MyCancerRisk’, an online cancer risk assessment tool developed by Check4Cancer has won the ‘Innovation in Health Tech’ award at the 2021 Laing Buisson Awards.

The prestigious Laing Buisson Awards celebrate industry excellence at every level of healthcare, and they received a record-breaking number of nominations for the 2021 awards in every single category, with 490 entries in total.

Professor Gordon Wishart, founder and CEO of Check4Cancer comments; ‘I am really proud of all our employees at Check4Cancer who helped design, develop and deploy our online cancer risk assessment tool within a two-year period. With the current disruption to UK cancer services, there has never been a more important time to support cancer screening in the corporate and insured sectors’.

Since founding Check4Cancer, Professor Wishart has disrupted the way that UK private cancer diagnostic and screening services are delivered by close collaboration with insured and corporate sectors. He is the former Director of the Cambridge Breast Unit and current Visiting Professor of Cancer Surgery at Anglia Ruskin University, with a strong track record in clinical research and modernisation of cancer services. In 2010 Professor Wishart led a team of scientists that developed the PREDICT breast cancer survival model, used worldwide (www.predict.nhs.uk).

For a full list of all the categories and winners of the Laing Buisson 2021 Awards, please click here.

Download Laing Buisson's November 2021 'HealthCare Markets' - The Path to Prevention 

For more information on MyCancerRisk, please click here.